Bavencio, which is developed for intravenous use, has been approved to treat adults and pediatric patients aged 12 years and older with mMCC. Bavencio is a human programmed
The patent case against Biogen for Tecfidera was filed last year by Coalition for Affordable Drugs led by hedge fund manager Kyle Bass. Following the patent board’s ruling,
The RELAX-AHF-2 trial demonstrated that serelaxin did not achieve its primary endpoints of reduction in cardiovascular death through day 180 or reduced declining heart failure through day five when
Xadago has been approved as add-on therapy to levodopa/carbidopa to treat PD, which affects up to 10 million patients across the globe. Developed in the late 1960s, Levodopa
Lilly stated that abemaciclib in combination with fulvestrant was demonstrated to be superior to fulvestrant plus placebo, with the former showing statistically significant improvement in PFS in comparison. The
In May 2014, both firms signed a worldwide research collaboration and license agreement to discover, develop and commercialize novel therapies against multiple immuno-oncology targets using CytomX’s Probody platform. The
Circassia has agreed to pay AstraZeneca $50m worth of its ordinary shares under the deal, which is expected to complete in the second quarter of this year. Circassia also
The trial demonstrated that Repatha has maximum reduced low-density lipoprotein cholesterol (LDL-C) levels, helping to decrease the risk of major cardiovascular events such as heart attacks, strokes and
The European Commission (EC) has approved the label extension application, granting three new indications for Cinryze, which expands its coverage to treat children with hereditary angioedema (HAE). Cinryze
The drug, Firdapse, was being tested on seven patients with Musk-MG, a rare subpopulation of MG patients. The seven-patient trial assessed the safety, tolerability and efficacy of Firdapse
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.